FindTrial
Sign In

The effect of miswak containing dentifrice in the management of periodontal disease in postmenopausal women.

Comparative assessment of clinical parameters and interleukin-6, osteocalcin levels in postmenopausal women with periodontitis following non-surgical periodontal therapy with and without miswak as an adjunctive dentifrice: an observational study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055572
Enrollment
56
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N958- Other specified menopausal and perimenopausal disorders

Interventions

Intervention1: NON SURGICAL PERIODONTAL THERAPY FOLLOWED BY THE APPLICATION OF A HERBAL DENTIFRICE: the current study evaluates the efficacy of the adjunctive use of miswak with NSPT in Post -menopaus

Sponsors

ABIRAMI J
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 2. Self-reported history of menopause with the history of cessation of menstrual cycle over 12months (WHO) According to AAP 2017 classification the following criteria were taken into consideration for evaluation of patients with Stage III periodontitis

Exclusion criteria

Exclusion criteria: 1. Patients above 54years of age. 2. Patients using tobacco of any form. 3. Patients with immunodeficiency disorders. 4. Patients with other systemic inflammatory conditions like sepsis, pneumonia, pleural effusion, intra-abdominal infections, inflammatory bowel disorders, inflammatory rheumatoid disorders, chronic kidney disease, cancers, diabetes, COPD, asthma, HIV and hepatitis will be excluded from the study. 5. History of periodontal treatment within the previous 6 months. 6. History of antibiotic therapy in the past 3 months. 7. Subjects who are not willing to participate in the study. 8. Patients on HRT. 9. Patients with a history of hysterectomy.

Design outcomes

Primary

MeasureTime frame
to evaluate clinical parameters and IL6Timepoint: BASELINE AND 6 MONTHS—

Secondary

MeasureTime frame
TO COMPARE AND CORRELATE THE IL6 LEVELS AND OSTEOCALCIN LEVELS IN POST MENOPAUSAL WOMEN USING A DENTIFRICE WITH AND WITHOUT MISWAK AS AN INGREDIENTTimepoint: 3MONTHS AND 6MONTHS—

Countries

India

Contacts

Public ContactABIRAMI J

SRM DENTAL COLLEGE RAMAPURAM

akashpsg@gmail.com9840870990

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026